Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · IEX Real-Time Price · USD
2.985
-0.065 (-2.13%)
Apr 26, 2024, 1:56 PM EDT - Market open
Protara Therapeutics Market Cap
Protara Therapeutics has a market cap or net worth of $33.73 million as of April 26, 2024. Its market cap has decreased by -2.52% in one year.
Market Cap
33.73M
Enterprise Value
-26.38M
1-Year Change
-2.52%
Ranking
Category
Stock Price
$2.99
Market Cap Chart
Since October 22, 2014, Protara Therapeutics's market cap has decreased from $140.90M to $33.73M, a decrease of -76.06%. That is a compound annual growth rate of -13.95%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 25, 2024 | 34.90M | 8.39% |
Apr 24, 2024 | 32.20M | -6.12% |
Apr 23, 2024 | 34.30M | -1.72% |
Apr 22, 2024 | 34.90M | 15.56% |
Apr 19, 2024 | 30.20M | -3.82% |
Apr 18, 2024 | 31.40M | 0.64% |
Apr 17, 2024 | 31.20M | -4.29% |
Apr 16, 2024 | 32.60M | 0.31% |
Apr 15, 2024 | 32.50M | -5.25% |
Apr 12, 2024 | 34.30M | -2.83% |
Apr 11, 2024 | 35.30M | -3.29% |
Apr 10, 2024 | 36.50M | -0.82% |
Apr 9, 2024 | 36.80M | -6.12% |
Apr 8, 2024 | 39.20M | -5.54% |
Apr 5, 2024 | 41.50M | -9.78% |
Apr 4, 2024 | 46.00M | -1.92% |
Apr 3, 2024 | 46.90M | -0.21% |
Apr 2, 2024 | 47.00M | -0.63% |
Apr 1, 2024 | 47.30M | 3.28% |
Mar 28, 2024 | 45.80M | 0.22% |
Mar 27, 2024 | 45.70M | -3.79% |
Mar 26, 2024 | 47.50M | 4.17% |
Mar 25, 2024 | 45.60M | -0.87% |
Mar 22, 2024 | 46.00M | 3.14% |
Mar 21, 2024 | 44.60M | -3.25% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Co-Diagnostics | 35.95M |
Brainstorm Cell Therapeutics | 35.88M |
Lucid Diagnostics | 34.88M |
Fortress Biotech | 34.81M |
Cyclo Therapeutics | 34.75M |
electroCore | 33.97M |
CASI Pharmaceuticals | 33.64M |
Precision Optics Corporation | 33.62M |